Haemonetics News

Haemonetics Price Target Raised to $125.00/Share From $115.00 by JMP Securities

Haemonetics Price Target Raised to $125.00/Share From $115.00 by JMP Securities

Dow JonesMay 11 01:02

4 Analysts Assess Haemonetics: What You Need To Know

During the last three months, 4 analysts shared their evaluations of Haemonetics (NYSE:HAE), revealing diverse outlooks from bullish to bearish.The table below provides a concise overview of recent ra

BenzingaMay 11 01:01

Haemonetics (HAE) Q4 Earnings Top Estimates, Margins Expand

Yahoo FinanceMay 10 22:53

Haemonetics Is Maintained at Outperform by Barrington Research

Haemonetics Is Maintained at Outperform by Barrington Research

Dow JonesMay 10 22:40

Barrington Research: Maintaining the Haemonetics (HAE.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $105.00 to $107.00.

Barrington Research: Maintaining the Haemonetics (HAE.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $105.00 to $107.00.

Zhitong FinanceMay 10 22:31

Barrington Research Maintains Outperform on Haemonetics, Raises Price Target to $107

Barrington Research analyst Michael Petusky maintains Haemonetics (NYSE:HAE) with a Outperform and raises the price target from $105 to $107.

BenzingaMay 10 22:30

Earnings Call Summary | Haemonetics(HAE.US) Q4 2024 Earnings Conference

The following is a summary of the Haemonetics Corporation (HAE) Q4 2024 Earnings Call Transcript:Financial Performance:Haemonetics Corporation saw an organic revenue growth of 10% in Q4 and 12% for th

Futu NewsMay 10 21:07 · Conference Call

Needham: Reiterates that Haemonetics (HAE.US) holds the rating.

Needham: Reiterates that Haemonetics (HAE.US) holds the rating.

Zhitong FinanceMay 10 17:51

Needham Reiterates Hold on Haemonetics

Needham analyst Mike Matson reiterates Haemonetics with a Hold.

Analyst UpgradesMay 10 17:50

Haemonetics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 — Needham Reiterates → Hold 04/12/2024 13.39% Barrington Research $105 → $105 Maintains Outper

BenzingaMay 10 17:49

Strong Buy: Haemonetics Corporation Set for Growth and Margin Expansion

TipRanksMay 10 12:57

Haemonetics (HAE) Gets a Hold From Needham

TipRanksMay 10 02:05

Haemonetics Expects 2024 Revenue Growth Of 5%-8% On Reported Basis And 0%-3% On Organic Basis

Haemonetics Expects 2024 Revenue Growth Of 5%-8% On Reported Basis And 0%-3% On Organic Basis

BenzingaMay 9 18:59

Haemonetics Corp Q4 Profit Decreases, But Beats Estimates

RTTNewsMay 9 18:14

Haemonetics Q4 2024 Adj EPS $0.90 Beats $0.89 Estimate, Sales $343.290M Beat $329.113M Estimate

Haemonetics Q4 2024 Adj EPS $0.90 Beats $0.89 Estimate, Sales $343.290M Beat $329.113M Estimate

BenzingaMay 9 18:10

Haemonetics 4Q Rev $343M >HAE

Haemonetics 4Q Rev $343M >HAE

Dow JonesMay 9 18:05

Press Release: Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website PR Newswire BOSTON, May 9, 2024 Financial release accessible online BOSTON, May 9, 2024 /PRNew

Dow JonesMay 9 18:00

Insider Sale at Haemonetics Corp (HAE): EVP, Chief Technology Officer Anila Lingamneni Sells ...

Yahoo FinanceMay 9 09:15

Haemonetics(HAE.US) Officer Sells US$218.98K in Common Stock

$Haemonetics(HAE.US)$ Officer Lingamneni Anila sold 2,305 shares of common stock on May 6, 2024 at an average price of $95 for a total value of $218.98K.Source: Announcement What is statement of chang

Futu NewsMay 9 05:42

Form 144 | Haemonetics(HAE.US) Officer Proposes to Sell 218.98K in Common Stocks

SEC FILLINGS DISCLOSED/ May 6, $Haemonetics(HAE.US)$ Officer Lingamneni Anila intends to sell 2,305 shares of its common stock on May 6, with a total market value of approximately $218.98K. Source:

Futu NewsMay 7 02:10